The Latest Breaking News from Baxter International

Baxter International is poised to release its second-quarter results this month, and analysts are projecting a double-digit earnings growth.

Despite Baxter International’s relatively underwhelming performance over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Bridge Industrial has withdrawn a controversial plan to replace the Deerfield campus with a warehouse and logistics facility. But the larger question about where to put such facilities, and their potential environmental impact, remains.

Plans call for Baxter’s architecturally significant Deerfield campus to be replaced by a warehouse facility. That would be a massive case of architectural heartbreak of the first order, architecture critic Lee Bey writes.

Baxter International, a maker of renal and hospital products, plans to lay off workers as part of a cost reduction plan aimed at addressing what’s been a challenging time for the company.

S&P 500 investors are playing a waiting game: When will the next recession hit? But it doesn't have to be a game of chicken, too.

Pulled from Benzinga Pro data, Baxter International (NYSE:BAX) showed a loss in earnings since Q4, totaling $73.00 million. Sales, on the other hand, increased by 5.49% to $3.71 billion during Q1.

Baxter International (NYSE:BAX) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that Baxter International will report an earnings per share (EPS) of $0.80.

The demand for medical equipment & supplies is rising exponentially with the emergence of severe illnesses such as the ongoing Coronavirus pandemic and the growing elderly population. So, Baxter International (BAX) and Becton Dickinson and Company (BDX) should benefit. But which of these two stocks is a better buy now?…